AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE
1 total filings · 0 classes · Active since Aug 2025
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 1 filings. The WikiTrademarks Expansion Score is 4/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed June 14, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 99358160 | AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE | Aug 26, 2025 | Pending | 005 Pharmaceuticals | Seqirus Inc. |
Weekly visibility reports showing how ChatGPT mentions AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark portfolio
What trademarks does AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE hold?
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals). The most recent filings are registered to Seqirus Inc..
How many trademarks does AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE. The brand has been actively filing since August 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE file most often?
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE's most active class is NICE Class 5 (Pharmaceuticals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark?
The most recent filings under the AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE mark are registered to Seqirus Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE expanding into new categories?
The current WikiTrademarks Expansion Score for AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE is 4 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark filings?
Click the Watch Brand button at the top of this page to add AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE to another owner · Browse all NICE classes · Most valuable brands